Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIR-NA for remission of prediabetes
2024-519903-88-00Phase 2Authorised
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of niacin in prediabetes (2 arms), sponsored by Universitätsklinikum Schleswig-Holstein. Primary endpoint: Remission of prediabetes. Planned start Mar 2026; status: authorised.
02
Drugs
niacin
03
Conditions
prediabetes
Beyond the preview
Go deeper on 2024-519903-88-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519903-88-00.